HTA - Health Technology Assessment Report Aztreonam in chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis Year: 2010 Date: 02 Jun 2010 Author: Source Barcelona: Catalan Agency for Health Technology Assessment and Research (CAHTA) YR: 2010 Participants Adult patients with cystic fibrosis with chronic pulmonary infections due to Pseudomonas aeruginosa Interventions Aztreonam Related topics Antibiotic treatment for stenotrophomonas maltophilia in people with cystic fibrosis Antibiotic treatment of early pseudomonas aeruginosa Antibiotics for pulmonary exacerbations Inhaled antibiotics in cystic fibrosis MRSA eradication in CF Prophylactic use of oral antistaphylococcal antibiotic Scheduled antibiotics every 3-4 months / symptom-based treatment